Senator Orrin Hatch and Senator Kamala Harris ask Attorney General Jeff Sessions to get the DEA to allow medical marijuana research; current and former executives of pharmaceutical distributors are scheduled to testify before Congress May 8 about their role in the opioid epidemic; 14 patients on Vieques, a Puerto Rican island just east of the main island, are flying 3 times a week for lifesaving dialysis more than 6 months after Hurricane Maria.
Bipartisan senators wrote Attorney General Jeff Sessions to ask him to cease efforts by the Drug Enforcement Agency (DEA) to slow medical marijuana research. Senator Orrin Hatch, R-Utah, and Senator Kamala Harris, D-California, said that they are concerned the Justice Department is effectively blocking the DEA from taking action on at least 25 formal applications from manufacturers to produce federally approved research-grade marijuana, The Hill reported. Such research is needed for “evidence-based decision making,” they wrote.
Current and former executives of pharmaceutical distributors are scheduled to testify before Congress May 8 about their role in the opioid epidemic, reported The Washington Post. The hearing before a House Energy and Commerce Committee oversight panel is being likened to when tobacco executives were called to testify before Congress in 1994. Under oath, the executives are expected to face tough questions about why their companies sent so many highly addictive pain pills into West Virginia and other states, fueling the drug crisis.
Fourteen patients on Vieques, a Puerto Rican island just east of the main island, are flying 3 times a week for lifesaving dialysis more than 6 months after Hurricane Maria because the only hospital and dialysis clinic was destroyed, Kaiser Health News reported. When patients with diabetes and kidney failure will be able to regain their treatments locally is uncertain, as federal, local officials, and nonprofit groups debate strategy and finances. The responsibility of paying for the flights, which turn into 12-hour ordeals to get from Vieques to the main island, continues to switch between groups.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More